Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
Oct 16 (Reuters) – Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious kidney condition, citing “strategic considerations”, according to a ...
10.16.2026 reuters.com , yahoo.com and 10 sites
Investing. com -- Vanda Pharmaceuticals Inc (NASDAQ: VNDA) shares fell 6. 2% in after-hours trading Wednesday after the company announced its anxiety drug VQW-765 failed to meet the primary endpoint i...
10.14.2026 Yahoo.com and 8 sites
Jacobs Solutions ( NYSE: J – Get Free Report ) had its target price decreased by stock analysts at KeyCorp from $168. 00 to $166. 00 in a report issued on Thursday, Benzinga reports. The firm presentl...
10.15.2026 Tickerreport.com and 71 sites
It's always a great day to be in Los Angeles, but yesterday it was especially wonderful. On October 15, Flow Space welcomed more than 400 attendees to its annual Women's Health Summit for a day of con...
10.16.2026 Yahoo.com
Ironwood Pharmaceuticals, Inc. ( ), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced that its Board of Directors appointed Chief Commercial Officer Tammi Gaskins as Chief Executive Officer and a member of the Board of Directors, effective January 1, 2027. On that date Chief Executive Officer Tom McCourt will retire from his current role and will remain a member of the Board of Directors....
10.16.2026 Stocktitan.net and 7 sites
This week, Chiefs Wire's Ed Easton Jr. spoke with Super Bowl-winning coach and Tampa Bay Buccaneers Senior football consultant Bruce Arians. In his interview with Easton Jr. , Arians discussed his wor...
10.18.2026 Usatoday.com
This week, Chiefs Wire's Ed Easton Jr. spoke with Super Bowl-winning coach and Tampa Bay Buccaneers Senior football consultant Bruce Arians. In his interview with Easton Jr. , Arians discussed his wor...
10.16.2026 Usatoday.com and 1 sites
Two oral presentations to highlight new 76-week data showing sustained proteinuria reduction and continued eGFR stabilization with a consistent long-term safety profile Additional presentations to hig...
10.19.2026 Globenewswire.com and 39 sites
BRUSSELS (dpa-AFX) - Swiss stocks moved higher on Thursday, extending gains to a fifth straight session, thanks to strong buying at several counters. In addition to digesting Swiss producer and import...
10.15.2026 Tradingview.com and 1 sitesSenior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical development, structural biology, and portfolio strategy depth as MindWalk prepares its programs for preclinical efficacy studies BOSTON — MindWa...
10.14.2026 Tradingview.com and 42 sites
